David A. Bennett

David A. Bennett

Auto-generated profile, based on publicly available information

David A. Bennett

Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, 60612, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2018 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
DBDavid A Bennett
David A Bennett
ABAron S Buchman
Aron S Buchman
PBPatricia A Boyle
Patricia A Boyle
LBLisa L Barnes
Lisa L Barnes
RWRobert S Wilson
Robert S Wilson
JSJulie A Schneider
Julie A Schneider
Background: The Religious Orders Study and Rush Memory and Aging Project are both ongoing longitudinal clinical-pathologic cohort studies of aging and Alzheimer’s disease (AD). Objectives: To summarize progress over the past five years and its implic

27 June 2006 in Neurology
Verified
Journal Article
Closed access
PDF file
DBD. A. Bennett
D. A. Bennett
JSJ. A. Schneider
J. A. Schneider
ZAZ. Arvanitakis
Z. Arvanitakis
JKJ. F. Kelly
J. F. Kelly
NAN. T. Aggarwal
N. T. Aggarwal
RWR. S. Wilson
R. S. Wilson
Objective: To examine the relation of National Institute on Aging–Reagan (NIA-Reagan) neuropathologic criteria of Alzheimer disease (AD) to level of cognitive function in persons without dementia or mild cognitive impairment (MCI). Methods: More than 2,000 persons without dementia participating in the Religious Orders Study or the Memory and Aging Project agreed to annual detailed clinical evaluation and brain donation. The studies had 19 neuropsychological performance tests in common that assessed five cognitive domains, including episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability. A total of 134 persons without cognitive impairment died and underwent brain autopsy and postmortem assessment for AD pathology using NIA-Reagan neuropathologic criteria for AD, cerebral infarctions, and Lewy bodies. Linear regression was used to examine the relation of AD pathology to level of cognitive function proximate to death. Results: Two (1.5%) persons met NIA-Reagan criteria for high likelihood AD, and 48 (35.8%) met criteria for intermediate likelihood; 29 (21.6%) had cerebral infarctions, and 18 (13.4%) had Lewy bodies. The mean Mini-Mental State Examination score proximate to death was 28.2 for those meeting high or intermediate likelihood AD by NIA-Reagan criteria and 28.4 for those not meeting criteria. In linear regression models adjusted for age, sex, and education, persons meeting criteria for intermediate or high likelihood AD scored about a quarter standard unit lower on tests of episodic memory (p = 0.01). There were no significant differences in any other cognitive domain. Conclusions: Alzheimer disease pathology can be found in the brains of older persons without dementia or mild cognitive impairment and is related to subtle changes in episodic memory.

17 August 2014 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
PJPhilip L De Jager
Philip L De Jager
GSGyan Srivastava
Gyan Srivastava
KLKatie Lunnon
Katie Lunnon
JBJeremy Burgess
Jeremy Burgess
LSLeonard C Schalkwyk
Leonard C Schalkwyk
DBDavid A Bennett
David A Bennett
Aging can lead to cognitive decline associated with neural pathology and Alzheimer's disease (AD). Here the authors scan the methylation status of CpGs across the entire genome of brain samples from aged subjects in an epigenome-wide association study (EWAS). Several loci, including ANK1, were associated with AD pathology, gene expression and AD genetic risk networks. We used a collection of 708 prospectively collected autopsied brains to assess the methylation state of the brain's DNA in relation to Alzheimer's disease (AD). We found that the level of methylation at 71 of the 415,848 interrogated CpGs was significantly associated with the burden of AD pathology, including CpGs in the ABCA7 and BIN1 regions, which harbor known AD susceptibility variants. We validated 11 of the differentially methylated regions in an independent set of 117 subjects. Furthermore, we functionally validated these CpG associations and identified the nearby genes whose RNA expression was altered in AD: ANK1, CDH23, DIP2A, RHBDF2, RPL13, SERPINF1 and SERPINF2. Our analyses suggest that these DNA methylation changes may have a role in the onset of AD given that we observed them in presymptomatic subjects and that six of the validated genes connect to a known AD susceptibility gene network.

1 June 2012 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
DBDavid A. Bennett
David A. Bennett
JSJulie A. Schneider
Julie A. Schneider
ABAron S. Buchman
Aron S. Buchman
LBLisa L. Barnes
Lisa L. Barnes
PBPatricia A. Boyle
Patricia A. Boyle
RWRobert S. Wilson
Robert S. Wilson
The Memory and Aging Project is a longitudinal, epidemiologic clinical-pathologic cohort study of common chronic conditions of aging with an emphasis on decline in cognitive and motor function and risk of Alzheimer’s disease (AD). In this manuscript, we first summarize the study design and methods. Then, we present data on: 1) the relation of motor function to cognition, disability, and death; 2) the relation of risk factors to cognitive and motor outcomes, disability and death; 3) the relation of neuropathologic indices to cognitive outcomes; 4) the relation of risk factors to neuropathologic indices; and 5) additional study findings. The findings are discussed and contextualized.

23 July 2002 in Neurology
Verified
Journal Article
Closed access
PDF file
DBD. A. Bennett
D. A. Bennett
RWR. S. Wilson
R. S. Wilson
JSJ. A. Schneider
J. A. Schneider
DED. A. Evans
D. A. Evans
LBL. A. Beckett
L. A. Beckett
JBJ. Bach
J. Bach
Background: Cognitive abilities of older persons range from normal, to mild cognitive impairment, to dementia. Few large longitudinal studies have compared the natural history of mild cognitive impairment with similar persons without cognitive impairment. Methods: Participants were older Catholic clergy without dementia, 211 with mild cognitive impairment and 587 without cognitive impairment, who underwent annual clinical evaluation for AD and an assessment of different cognitive abilities. Cognitive performance tests were summarized to yield a composite measure of global cognitive function and separate summary measures of episodic memory, semantic memory, working memory, perceptual speed, and visuospatial ability. The authors compared the risk of death, risk of incident AD, and rates of change in global cognition and different cognitive domains among persons with mild cognitive impairment to those without cognitive impairment. All models controlled for age, sex, and education. Results: On average, persons with mild cognitive impairment had significantly lower scores at baseline in all cognitive domains. Over an average of 4.5 years of follow-up, 30% of persons with mild cognitive impairment died, a rate 1.7 times higher than those without cognitive impairment (95% CI, 1.2 to 2.5). In addition, 64 (34%) persons with mild cognitive impairment developed AD, a rate 3.1 times higher than those without cognitive impairment (95% CI, 2.1 to 4.5). Finally, persons with mild cognitive impairment declined significantly faster on measures of episodic memory, semantic memory, and perceptual speed, but not on measures of working memory or visuospatial ability, as compared with persons without cognitive impairment. Conclusions: Mild cognitive impairment is associated with an increased risk of death and incident AD, and a greater rate of decline in selected cognitive abilities.

1 June 2012 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
DBDavid A. Bennett
David A. Bennett
JSJulie A. Schneider
Julie A. Schneider
ZAZoe Arvanitakis
Zoe Arvanitakis
RWRobert S. Wilson
Robert S. Wilson
The Religious Orders Study is a longitudinal clinical-pathologic cohort study of aging and Alzheimer’s disease (AD). In this manuscript, we summarize the study methods including the study design and describe the clinical evaluation, assessment of risk factors, collection of ante-mortem biological specimens, brain autopsy and collection of selected postmortem data. The results: 1) review the relation of neuropathologic indices to clinical diagnoses and cognition proximate to death; 2) examine the relation of risk factors to clinical outcomes; 3) examine the relation of risk factors to measures of neuropathology; and 4) summarize additional study findings. We then discuss and contextualize the study findings.